Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation.
Iori AP, Torelli GF, De Propris MS, Milano F, Pupella S, Gozzer M, Mancini F, Milani ML, Intoppa S, Cerretti R, Lucarelli B, Valle V, Malandruccolo L, Iannella E, Arleo E, Guarini A, Foà R. Iori AP, et al. Among authors: gozzer m. Transplantation. 2008 Feb 15;85(3):386-90. doi: 10.1097/TP.0b013e3181622e36. Transplantation. 2008. PMID: 18322430
Anti-HLA donor-specific antibodies in allogeneic stem cell transplantation: management and desensitization protocol.
La Rocca U, Perrone MP, Piciocchi A, Cinti P, Barberi W, Gozzer M, Baftii MS, Torelli GF, Quattrocchi L, Gesuiti P, Lattanzi R, Cavallari C, Ricci R, Laurenti L, Foà R, Girelli G, Iori AP. La Rocca U, et al. Among authors: gozzer m. Bone Marrow Transplant. 2019 Oct;54(10):1717-1720. doi: 10.1038/s41409-019-0497-1. Epub 2019 Mar 4. Bone Marrow Transplant. 2019. PMID: 30833741 No abstract available.
Managing leukapheresis in adult and pediatric patients eligible for chimeric antigen receptor T-cell therapy: suggestions from an Italian Expert Panel.
Leone G, Baldini V, Bramanti S, Crocchiolo R, Gattillo S, Ermini S, Giudice V, Ferrero I, Moscato T, Milani R, Gozzer M, Piccirillo N, Tassi C, Tassi V, Coluccia P. Leone G, et al. Among authors: gozzer m. Blood Transfus. 2023 Nov 23;21(6):514-525. doi: 10.2450/BloodTransfus.471. Blood Transfus. 2023. PMID: 37146295 Free PMC article.
Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization.
Romeo A, Chierichini A, Spagnoli A, Vittori M, Vacca M, Gozzer M, Spadea A, Anaclerico B, Dessanti ML, D'Andrea M, Toglia G, Annino L, Petti MC, Mengarelli A, Arcese W; Rome Transplant Network. Romeo A, et al. Among authors: gozzer m. Transfusion. 2010 Nov;50(11):2432-46. doi: 10.1111/j.1537-2995.2010.02723.x. Transfusion. 2010. PMID: 20553434
A good manufacturing practice method to ex vivo expand natural killer cells for clinical use.
Torelli GF, Rozera C, Santodonato L, Peragine N, D'agostino G, Montefiore E, Napolitano MR, Monque DM, Carlei D, Mariglia P, Pauselli S, Gozzer M, Bafti MS, Girelli G, Guarini A, Belardelli F, Foà R. Torelli GF, et al. Among authors: gozzer m. Blood Transfus. 2015 Jul;13(3):464-71. doi: 10.2450/2015.0231-14. Epub 2015 Jan 30. Blood Transfus. 2015. PMID: 25761309 Free PMC article. Clinical Trial.
26 results